HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

triphenyltin chloride

see also triphenyltin acetate, triphenyltin hydroxide

Also Known As:

chlorotriphenylstannane

Networked: 12 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - Organotin Compounds: 41
    - triphenyltin chloride: 12

Experts

1.	Brtko, Julius: 2 articles (01/2018 - 06/2015)
2.	Miura, Yoshikazu: 2 articles (09/2012 - 11/2006)
3.	Bobal, Pavel: 1 article (01/2018)
4.	Bohacova, Viera: 1 article (01/2018)
5.	Breier, Albert: 1 article (01/2018)
6.	Cagala, Martin: 1 article (01/2018)
7.	Kontar, Szilvia: 1 article (01/2018)
8.	Otevrel, Jan: 1 article (01/2018)
9.	Pavlikova, Lucia: 1 article (01/2018)
10.	Seres, Mario: 1 article (01/2018)

Related Diseases

1.	Hemolysis 03/01/1987 - "The relatively lipophilic compound, triphenyltin chloride, appeared to be anomalous because it did not readily promote hemolysis or induce the formation of intramembranous aggregates in human erythrocytes. " 03/01/1987 - "Organotin compounds examined in this study exhibited a relative order of potency for induction of in vitro hemolysis in human erythrocytes as follows: tri-n-butyltin greater than tri-n-propyltin greater than tetra-n-butyltin greater than triphenyltin chloride greater than tri-n-ethyltin bromide greater than dibutyltin dichloride greater than stannous chloride greater than tri-n-methyltin chloride = butyltin chloride dihydroxide. "
2.	Body Weight (Weight, Body) 06/01/2006 - "Specimens of Bolinus brandaris (neogastropod) were injected with a single dose of 500 ng/g body weight (b.w.) of tributyltin chloride (TBTCl) or triphenyltin chloride (TPTCl), or a mixture of both compounds (250 ng TBT/g b.w.+250 ng TPT/g b.w.), for a period of up to 31 days. " 09/28/2012 - "Oral administration of triphenyltin chloride (TPT) (6 mg/100g body weight) inhibits insulin secretion by decreasing glucose-induced cytoplasmic Ca(2+) concentration ([Ca(2+)](i)) in pancreatic β-cells of the hamster. " 11/01/2006 - "Oral administration of triphenyltin chloride (TPT) (60 mg/kg body weight) inhibits the insulin secretion by decreasing the cytoplasmic Ca2+ concentration ([Ca2+]i) induced by glucose-dependent insulinotropic polypeptide (GIP) in pancreatic beta-cells of the hamster. "
3.	Breast Neoplasms (Breast Cancer) 05/01/2016 - "Anticancer effects of tributyltin chloride and triphenyltin chloride in human breast cancer cell lines MCF-7 and MDA-MB-231." 06/01/2015 - "A comparison of the effects of tributyltin chloride and triphenyltin chloride on cell proliferation, proapoptotic p53, Bax, and antiapoptotic Bcl-2 protein levels in human breast cancer MCF-7 cell line." 06/01/2015 - "Here we present the effects of tributyltin chloride (TBT-Cl) and triphenyltin chloride (TPT-Cl) on cell proliferation, expression of proapoptotic p53, Bax, and antiapoptotic Bcl-2 proteins in human breast cancer MCF-7 cell line. "
4.	Glucose Intolerance 01/01/1996 - "We performed an intravenous glucose tolerance test (IVGTT) after the administration of triphenyltin chloride (TPTCl-Ad) in hamsters in order to confirm the presence of glucose intolerance and to clarify the pathogenesis of TPTCl-induced glucose intolerance. " 01/01/1996 - "Triphenyltin chloride induces glucose intolerance by the suppression of insulin release from hamster pancreatic beta-cells."
5.	Neoplasms (Cancer) 01/15/2016 - "In this work, a novel chrysin-organotin (Chry-Sn) compound with enhanced anticancer activities was synthesized by the reaction of chrysin and triphenyltin chloride, and its potential anticancer effects against cancer cells were measured using various methods. "

Related Drugs and Biologics

1.	tributyltin
2.	Chlorides
3.	Organotin Compounds
4.	Bromides
5.	dibutyldichlorotin
6.	n-butyltin
7.	methyltin
8.	stannous chloride (tin chloride)
9.	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)
10.	Glucose (Dextrose)

Related Therapies and Procedures

1.	Oral Administration